Bench International

October 2022

Insight by: Dave Whelan “He was headed for Beverly Hills to be a plastic surgeon…. But he took an exit to a town that didn't take plastic.” Quick, name that movie! If you guessed Doc Hollywood, you get a star on my personal walk of fame. Or...

Insight by: Steve Martin The competition for talent in life sciences, from hiring through retention, has arguably never been fiercer, and at the even narrower intersection of IT talent and life sciences, it has been transformed into a veritable battlefield.  While the pandemic is often associated...

Insight by: Debbie Lin In a recent speech this September to leaders in science and medicine commemorating President John F. Kennedy’s space race to the Moon, President Biden spoke about his goal to win the race against cancer by highlighting a federal program, a part of...

Insight by: Steve Martin There have been scores of articles written, and studies conducted, highlighting the statistics around unsuccessful IT outsourcing deals – many establishing the failure rate at well above 50%.  Moreover, if we study the hardest hit industries, healthcare is often cited as one...

Insight by: Dave Whelan Can you believe that it has been over 25 years since Jerry Maguire* entered our lives? Cameron Crowe’s renegade sports agent, played brilliantly by Tom Cruise, has been part of our collective consciousness for longer than the average age of an NFL...

Insight by: Debbie Lin The US, historically, has been characterized by vast inequities in health outcomes across socio-economic groups. Poor outcomes across diseases from tuberculosis to cardiovascular disease were found to be associated with basic social infrastructure problems such as poor housing, malnutrition and poor education...

Insight by: Jon Warner Greater data connectivity, interoperability and increasing consumer engagement are key elements that are expected to shape the future of health. Within the next 10-15 years, the consumer—rather than health plans or providers—will determine when, where, and with whom he or she engages...

Interview with Linda Sierra You work in two of the three top biotech markets in the U.S.; what trends are you seeing in San Diego and San Francisco? There is no debate it is a turbulent time in life science. Most CEOs are afraid they won't be...